CardioTech to Sell Gish Biomedical to Medos for $7.5M

 

July 6, 2007

July 6, 2007 - CardioTech International Inc. announced that it has signed an agreement to sell its Gish Biomedical Inc. subsidiary in a stock transaction to Medos Medizintechnik AG (Medos) for nearly $7.5 million in a move that will allow CardioTech to invest the proceeds in its growth initiatives.

Medos Medizintechnik AG is a developer and manufacturer of medical devices for cardiac surgery, extracorporeal membrane oxygenation and Ventricle Assist Devices (VAD), and the purchase of Gish provides Medos with an opportunity to enter the U.S. market for disposable medical products used in cardiopulmonary surgery. The sale of Gish is expected to close on or about July 9, 2007.

For more information: www.cardiotech-inc.com

The content of this field is kept private and will not be shown publicly.
Type the characters you see in this picture. (verify using audio)
Type the characters you see in the picture above; if you can't read them, submit the form and a new image will be generated. Not case sensitive.